Replimune Group, Inc. 4

CFO Emily Luisa Hill sold 9,256 shares of Replimune Group, Inc. common stock at a weighted average price of $14.28 per share in an automatic sell-to-cover transaction tied to RSU vesting.

On August 17, 2026, Replimune Group, Inc. Chief Financial Officer Emily Luisa Hill executed an automatic “sell to cover” transaction in connection with the partial vesting of her restricted stock units, disposing of 9,256 shares of common stock at a weighted average price of $14.28 per share, for proceeds of approximately $132,000 to satisfy tax withholding obligations. The sale was effected pursuant to an irrevocable provision in the RSU award agreements and is characterized as non-discretionary, rather than a voluntary open-market sale. Following this transaction, Hill beneficially owned 215,852 shares of Replimune common stock, and using the reported sale price as a proxy for current market value, her post-transaction holdings are worth an estimated $3.08 million.

Filing Facts

CIK

1737953

Ticker

REPL

Form

4

Source Type

fda

Accession

0001104659-26-098868

Alert Tier

5